55.99160 USD
0.6197
1.09%
Last update Dec 16, 4:24 PM GMT
Market closed
Day range
55.5
57.69000
Previous close
56.61130
Open
55.5
Access this stock data via API
Subscribe
Crispr Therapeutics AG
55.99
0.62
1.09%

Statistics

Valuation metrics
Market cap
2.91B
Enterprise value
3.65B
Trailing P/E (ttm)
0.15
Forward P/E
PEG ratio
Price/Sales (ttm)
Price/Book (mrq)
2.74
Enterprise Value/Revenue
95.14
Enterprise Value/EBITDA
-7.94
Overview
Shares outstanding
51.90M
Float
94.80M
Shares short
% Held by insiders
1.61%
% Held by institutions
77.94%
Average volume (10 days)
4.54K
Average volume (90 days)
5.25K
Price summary
52-Week low
30.04
52-Week high
78.47
52-Week change
23.14 77.0%
Beta
1.73
50-Day moving average
71.57
200-Day moving average
58.84
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Aug 31, 2022
Profitability
Profit margin
0
Operating margin
-14,854.78%
Operational effectiveness
Return on assets
-13.28%
Return on equity
-25.33%
Income statement
Revenue (ttm)
38.34M
Revenue per share (ttm)
0.44
Quarterly revenue growth (yoy)
47.70%
Gross profit (ttm)
-430.67M
EBITDA
-459.48M
Net income to common (ttm)
-488.30M
Diluted EPS (ttm)
3.86
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
1.92B
Total cash per share (mrq)
20.10
Total debt (mrq)
211.02M
Total Debt/Equity (mrq)
11.01
Current ratio (mrq)
1,621.70%
Book value per share (mrq)
20.41
Cash flow
Cash flow statement
-302.49M
Levered free cash flow (LFCF)
-206.82M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 2 hours 13 minutes

05:01
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).